Arcturus Therapeutics Holdings Inc (ARCT)

NASDAQ
13.62
-0.40(-2.85%)
After Hours
14.30
+0.68(+4.99%)
- Real-time Data
  • Volume:
    489,316
  • Day's Range:
    13.10 - 14.18
  • 52 wk Range:
    11.70 - 51.58

ARCT Overview

Prev. Close
14.02
Day's Range
13.1-14.18
Revenue
40.56M
Open
13.78
52 wk Range
11.7-51.58
EPS
-6.27
Volume
489,316
Market Cap
361.97M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
461,868
P/E Ratio
-2.28
Beta
2.74
1-Year Change
-73.14%
Shares Outstanding
26,576,357
Next Earnings Date
Nov 07, 2022
What is your sentiment on Arcturus Therapeutics Holdings Inc?
or
Market is currently closed. Voting is open during market hours.

Arcturus Therapeutics Holdings Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Arcturus Therapeutics Holdings Inc Analysis

Arcturus Therapeutics Holdings Inc Company Profile

Arcturus Therapeutics Holdings Inc Company Profile

Employees
177

Arcturus Therapeutics Holdings Inc. is a late-stage global clinical messenger ribonucleic acid (mRNA) medicines company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its mRNA platform, the Company's lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose levels. The Company's products under developmental stage using STARR technology are ARCT-021, ARCT-154 and ARCT-165. Its COVID-19 vaccine candidate, ARCT-021, which is based on its STARR technology platform is through Phase II clinical trials. Its LUNAR-FLU Vaccine consists of Liver Franchise ARCT-810 (LUNAR-OTC) and Lung Franchise ARCT-032 (LUNAR-CF).

Read More

Analyst Price Target

Average55.55 (+307.82% Upside)
High140
Low8
Price13.62
No. of Analysts11
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell
  • hi, today earning report (no paricoular financial data i'm aspecting), but at what time exactly?
    0
    • compare to Moderna this stock priceless!! but Arct vaccina target and COVID variants
      0
      • ready to fly
        2
        • 🚀🚀🚀
          1
          • 💪
            1
            • A forgotten world...
              0
              • Will this company eventually end up bankruptcy?
                4
            • Earning reporting,  Pre market or after close?
              0
              • Earing reports is disappointed, a fall knive.
                0
            • Let's start the new uptrend
              0
              • It broke the 35 supporting level
                0
                • What will happen after the Q1 earning report?
                  0